US Patent Issued to Medda on Aug. 11 for "Modulating sensory perceptions during psychedelic induced therapy" (Michigan, Utah Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,786, issued on Aug. 11, was assigned to Medda Inc. (Ira, Mich.).

"Modulating sensory perceptions during psychedelic induced therapy" was invented by Caleb McClain (Ira, Mich.), Jeffrey Humpherys (Lehi, Utah) and Mounir Bendahmane (Canton, Mich.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention extends to methods, systems, and computer program products for modulating sensory perceptions during psychedelic induced therapy. Remote distributed virtual environments can be created enabling virtual group psychedelic therapy. Visual, auditory, and olfactory devices can be used to alter a patients' baseline sensory perceptions and obfuscat...